Literature DB >> 12351417

Increased bone marrow allograft rejection by depletion of NK cells expressing inhibitory Ly49 NK receptors for donor class I antigens.

Arati Raziuddin1, Dan L Longo, Michael Bennett, Robin Winkler-Pickett, John R Ortaldo, William J Murphy.   

Abstract

Natural killer (NK) cells are the major effectors of acute rejection of incompatible bone marrow cell (BMC) grafts in lethally irradiated mice. The immunogenetics of BMC rejection are largely controlled by the coexpression (or not) of inhibitory and stimulatory Ly49 receptors whose ligands are class I major histocompatibility complex (MHC) molecules. The majority of the BMC rejection studies involved low numbers of BMCs that were resisted by host NK cells. In the present study, larger numbers of BMCs were given in which rejection was not detected and the role of different Ly49 NK subsets not presumably involved in the rejection of a particular BMC haplotype was examined. Surprisingly, the data show that the removal of NK cell subsets expressing Ly49 inhibitory receptors for donor class I antigens, which would be predicted to have no effect on the BMC rejection capability, resulted in the marked rejection of BMCs where no resistance was normally seen. These results extend the "missing self" hypothesis to suggest that NK Ly49 inhibitory receptors can both inhibit activation and killing by those cells, but also can in some way influence the function of NK cells that do not express that inhibitory receptor in a cell-cell interaction. This suggests that caution must be exercised before removal of host NK cell subset is applied clinically because enhanced BMC rejection may result. Altering the balance of Ly49 NK subsets may also affect other in vivo activities of these cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12351417     DOI: 10.1182/blood.V100.8.3026

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  11 in total

1.  Suppression of natural killer cell-mediated bone marrow cell rejection by CD4+CD25+ regulatory T cells.

Authors:  Isabel Barao; Alan M Hanash; William Hallett; Lisbeth A Welniak; Kai Sun; Doug Redelman; Bruce R Blazar; Robert B Levy; William J Murphy
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-27       Impact factor: 11.205

2.  Mouse Ly49G2+ NK cells dominate early responses during both immune reconstitution and activation independently of MHC.

Authors:  Isabel Barao; Maite Alvarez; Erik Ames; Mark T Orr; Heather E Stefanski; Bruce R Blazar; Lewis L Lanier; Stephen K Anderson; Doug Redelman; William J Murphy
Journal:  Blood       Date:  2011-04-15       Impact factor: 22.113

3.  Mouse NK cell-mediated rejection of bone marrow allografts exhibits patterns consistent with Ly49 subset licensing.

Authors:  Kai Sun; Maite Alvarez; Erik Ames; Isabel Barao; Mingyi Chen; Dan L Longo; Doug Redelman; William J Murphy
Journal:  Blood       Date:  2011-12-19       Impact factor: 22.113

4.  Efficacy and limitations of natural killer cell depletion in cyclophosphamide-induced tolerance.

Authors:  Ichiro Shimizu; Yukihiro Tomita; Shinji Okano; Toshiro Iwai; Takashi Kajiwara; Tatsushi Onzuka; Ryuji Tominaga
Journal:  Surg Today       Date:  2007-01-01       Impact factor: 2.549

5.  NK cells interfere with the generation of resistance against mycoplasma respiratory infection following nasal-pulmonary immunization.

Authors:  Sheetal Bodhankar; Mathew D Woolard; Xiangle Sun; Jerry W Simecka
Journal:  J Immunol       Date:  2009-07-22       Impact factor: 5.422

6.  Mouse host unlicensed NK cells promote donor allogeneic bone marrow engraftment.

Authors:  Maite Alvarez; Kai Sun; William J Murphy
Journal:  Blood       Date:  2016-01-06       Impact factor: 22.113

7.  Blocking NK cell inhibitory self-recognition promotes antibody-dependent cellular cytotoxicity in a model of anti-lymphoma therapy.

Authors:  Liat Binyamin; R Katherine Alpaugh; Tracey L Hughes; Charles T Lutz; Kerry S Campbell; Louis M Weiner
Journal:  J Immunol       Date:  2008-05-01       Impact factor: 5.422

8.  Differential expression of the Ly49G(B6), but not the Ly49G(BALB), receptor isoform during natural killer cell reconstitution after hematopoietic stem cell transplantation.

Authors:  Isabel Barao; Paul W Wright; Can M Sungur; Stephen K Anderson; Doug Redelman; William J Murphy
Journal:  Biol Blood Marrow Transplant       Date:  2013-07-31       Impact factor: 5.742

9.  Murine NK-cell licensing is reflective of donor MHC-I following allogeneic hematopoietic stem cell transplantation in murine cytomegalovirus responses.

Authors:  Can M Sungur; Yajarayma J Tang-Feldman; Anthony E Zamora; Maite Alvarez; Claire Pomeroy; William J Murphy
Journal:  Blood       Date:  2013-07-01       Impact factor: 22.113

10.  Contrasting effects of anti-Ly49A due to MHC class I cis binding on NK cell-mediated allogeneic bone marrow cell resistance.

Authors:  Maite Alvarez; Can M Sungur; Erik Ames; Stephen K Anderson; Claire Pomeroy; William J Murphy
Journal:  J Immunol       Date:  2013-06-10       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.